Search the Newsreel

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

This article identifies 12 information technology stocks that are experiencing significant movement in Wednesday's pre-market session. It highlights both gainers, such as T3 Defense, Braiin, Socket Mobile, Aeluma, Manhattan Associates, and UTime, along with their respective percentage increases and market caps. The article also …

BrainsWay schedules business operations update for Aug. 12 webcast

BrainsWay (NASDAQ & TASE: BWAY) announced it will report its second quarter 2026 financial results and operational highlights before the U.S. market opens on Wednesday, August 12, 2026. The company will host an English conference call and webcast at 8:30 AM Eastern Time to …

Harel Insurance (BWAY) reports 3.27M-share beneficial stake in Brainsway

Harel Insurance Investments & Financial Services Ltd. has reported a beneficial ownership of 3,265,397 Ordinary Shares in Brainsway Ltd. (BWAY), which constitutes 8.3% of the company's outstanding shares. The majority of these shares are held on behalf of public investors through various funds and …

Brainsway Ltd Revenue Breakdown – TASE:BWAY

This article provides a revenue breakdown for Brainsway Ltd (TASE:BWAY), highlighting that the United States is its largest contributing region. In the past year, the U.S. accounted for 152.52 million ILS in revenue, an increase from 123.00 million ILS the previous year. The data …

Braime Group PLC Class A Revenue Breakdown – LSE:BMT

Brainsway Ltd. Sponsored ADR $BWAY Stock Position Raised by Masters Capital Management LLC

Masters Capital Management LLC significantly increased its stake in Brainsway Ltd. Sponsored ADR (BWAY) by 65% in the first quarter, now owning 1.65 million shares. The medical device company exceeded Q1 earnings estimates, reporting $0.12 per share versus $0.05 anticipated, and surpassed revenue expectations …

Brainsway Ltd (BWAY) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Brainsway Ltd (BWAY) stock, focusing on its dividend history and planned stock splits. It notes that no dividends have been distributed in the past five years and highlights a 1-for-2 stock split scheduled for February 17, 2026. Current …

BrainsWay Market Sentiment

This article provides an overview of BrainsWay (BWAY) market sentiment, including analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus with 5 analysts, a low short interest of 0.6%, and bullish options flow, indicating a positive market outlook …

Brainsway Ltd|Price:15.970|Chg%:-0.540

Brainsway Ltd (BWAY) is an Israel-based company specializing in medical devices for neurological and psychopathological disorders. The company's primary product is the Transcranial Magnetic Stimulation (TMS) system, which non-invasively stimulates deep brain structures for various clinical applications, including major depressive disorders and obsessive-compulsive disorder. …

Zacks Names Brainsway (NASDAQ: BWAY) Bull Of The Day While Lululemon (NASDAQ: LULU) Earns Bear Designation

Zacks Equity Research has named Brainsway (NASDAQ: BWAY) its Bull of the Day due to strong revenue growth, expanding insurance coverage for its Deep TMS therapy, and a positive outlook for future earnings. Conversely, Lululemon (NASDAQ: LULU) received the Bear of the Day designation …

Brainsway Ltd (BWAY) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Brainsway Ltd (BWAY), indicating a current valuation score of 5.10, ranking it 192 out of 200 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of 34.82, noting its position relative to …

H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $17

H.C. Wainwright has reiterated its Buy rating for Brainsway (BWAY.US), maintaining a target price of $17. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The decision reflects confidence in Brainsway's financial prospects and market position.

BRAI.NB|Price:6.180|Chg%:+0.545

This page provides detailed company information for Braiin Ltd (BRAI.NB), including its stock price, market capitalization, and key executive details. It lists the CEO, IPO date, and address, along with a roster of company executives and their shareholdings. The company's top shareholder, Mr. Natraj …

Brainsway (NASDAQ:BWAY) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen has downgraded Brainsway (NASDAQ:BWAY) from "buy" to "hold," despite other brokerages maintaining bullish ratings. The company still holds a consensus "Buy" rating with an average target price of $15.67 from analysts, and recently surpassed earnings expectations. Brainsway, a medical device company, …

H.C. Wainwright reiterates Brainsway stock rating on strategic investments By Investing.com

H.C. Wainwright reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following Brainsway's strategic minority equity investments in Radial Health and Sound Minds Behavioral. These investments are part of Brainsway's long-term plan to drive revenue and equity value. The company has …

Bull of the Day: Brainsway (BWAY)

Brainsway (BWAY) is a medical device company treating mental health disorders from major depressive disorder and OCD to substance abuse and cigarette addiction. Its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform uses a rapidly changing magnetic field to induce a small electrical current …

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

Braiin (NASDAQ:BRAI) Shares Up 6.4% - Still a Buy?

Braiin (NASDAQ:BRAI) shares increased by 6.4% to $5.64 on Thursday, with trading volume significantly below average. Analyst ratings are mixed, leading to a consensus "Hold" rating with an average price target of $10.00. The company is an Australian AI/ML technology business focusing on agriculture, …

Price-Driven Insight from (BWAY) for Rule-Based Strategy

This article provides a price-driven analysis for Brainsway Ltd. (NASDAQ: BWAY), highlighting strong near and mid-term sentiment, resistance testing, and an exceptional risk-reward short setup. It details three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop loss …

BTIG Initiates Brainsway(BWAY.US) With Buy Rating, Announces Target Price $18

BTIG has initiated coverage on Brainsway (BWAY.US) with a Buy rating. The firm has set a target price of $18 for the company's shares. This initiation signals analyst confidence in Brainsway's future performance.

BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100

BrainsWay Ltd (BWAY) shares rose 4.9% to $16.53, a significant increase year-to-date and over the past year. However, GuruFocus's GF Value™ indicates the stock is 138.2% overvalued at this price, suggesting a lack of margin of safety. While its GF Score™ of 65/100 (Above …

BrainsWay Announces Strategic Investment in Radial Health, Inc.

BrainsWay has invested $3 million in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This minority equity investment is part of Radial's Series A financing and aims to expand access to advanced noninvasive mental health treatments like …

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by Analysts

Five analysts have issued a consensus "Buy" rating for Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY), with an average 12-month price target of $15.67. Recent analyst actions, including new coverage and upgrades, highlight positive sentiment. The company also surpassed Q1 earnings expectations, reporting an EPS of …

Brainsway (NASDAQ:BWAY) Coverage Initiated by Analysts at BTIG Research

BTIG Research has initiated coverage on Brainsway (NASDAQ:BWAY) with a "buy" rating and an $18 price target, indicating a 14.4% potential upside. This positive sentiment aligns with other recent analyst upgrades and the company's stronger-than-expected quarterly earnings, which surpassed estimates for both EPS and …

BrainsWay (NASDAQ: BWAY) makes $3M strategic bet on Radial Health

BrainsWay Ltd. announced a $3 million minority equity investment in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This strategic investment is part of Radial's Series A financing and aligns with BrainsWay's strategy to expand awareness and …

A $3M BrainsWay Investment Is Expected to Support Radial's M&A Exploration

BrainsWay (BWAY) has announced a $3 million strategic minority equity investment in Radial Health, a management services organization focusing on Brain Medicine clinics. This investment is part of Radial's Series A financing round and aligns with BrainsWay's strategy to expand access to advanced psychiatric …

BrainsWay invests $3 million in Radial Health network By Investing.com

BrainsWay Ltd. has announced a $3 million minority equity investment in Radial Health, Inc., a management services organization focused on Brain Medicine clinics. This investment, part of Radial's Series A financing round, aims to expand awareness and access to noninvasive mental health treatments and …

BrainsWay Ltd. (BWAY) Q1 2026 Earnings: EPS Surpasses Estimates by Nearly 7%, Shares Rally 6% - One-Time Loss Impact

BrainsWay Takes Minority Stake in Sound Minds Behavioral to Expand Interventional Psychiatry Reach

BrainsWay has made a $500,000 minority investment in Sound Minds Behavioral, an outpatient mental health platform. This strategic move aims to expand BrainsWay's presence in the Mid-Atlantic market and increase access to innovative mental health care, while BrainsWay continues to focus on its Deep …

Brainsway stock rating reiterated at Buy by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating on Brainsway (NASDAQ:BWAY) with a $17.00 price target, following the company's strategic equity investment in Sound Minds Behavioral. The medical device company's stock has shown strong performance, surging 156% over the past year. Brainsway's financial flexibility, with …

BRSYF SEC Filings - Brainsway 10-K, 10-Q, 8-K Forms

This article provides a comprehensive overview of Brainsway (BRSYF) SEC filings, including 10-K, 10-Q, and 8-K forms, focusing on recent insider ownership reports. It details the equity holdings, stock options, and restricted stock units of several key executives and directors, such as David Zacut, …

BrainsWay invests USD 500,000 for minority stake in Sound Minds Behavioral

BrainsWay will invest $500,000 for a minority stake in Sound Minds Behavioral, an outpatient behavioral health platform. This investment is part of a strategic equity financing round. The original content was published by Brainsway Ltd. via GlobeNewswire.

Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.

Sound Minds Behavioral announced it expects to receive $0.5 million in funding from BrainsWay Ltd. This investment, confirmed on July 16, 2026, involves BrainsWay Ltd. acquiring a minority equity stake in Sound Minds Behavioral. The security issued for this transaction will be a preferred, …

BrainsWay invests $500,000 in Sound Minds Behavioral By Investing.com

BrainsWay Ltd. announced a $500,000 investment for a minority stake in Sound Minds Behavioral, an outpatient behavioral health platform operating in several Mid-Atlantic states. This strategic investment allows BrainsWay to support partners' growth while focusing on its Deep TMS technology. The company, which has …

BrainsWay (NASDAQ: BWAY) invests $500K in Sound Minds Behavioral

BrainsWay Ltd. announced a strategic minority investment of $500,000 in Sound Minds Behavioral, an outpatient behavioral health platform. This investment, made through a preferred, annually compounding security, aims to expand access to interventional psychiatry solutions, leveraging BrainsWay's Deep Transcranial Magnetic Stimulation platform. Sound Minds …

Four-State Behavioral Health Platform Adds BrainsWay as Partner

BrainsWay (NASDAQ & TASE: BWAY) announced a strategic minority-stake investment of $500,000 in Sound Minds Behavioral, an outpatient behavioral health platform operating in Connecticut, Pennsylvania, New Jersey, and New York. This investment, structured as a preferred, annually compounding security, supports BrainsWay's strategy to partner …